
Biopharm Products Development and Innovation Private Limited
About Biopharm Products Development and Innovation Private Limited
Data last updated:
Biopharm Products Development and Innovation Private Limited is a private limited company based in Cuttack, Odisha, India. It operates in the social science research segment of the research and development sector. It was incorporated on 19 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U73200OR2020PTC033481.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹50,000. It is led by directors Bidhubhusan Badu (Managing Director) and Prajna Paramita Badu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 1532/3135 At – Ekbaruan Po – Niali, Cuttack, Odisha, India – 754294.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.68 Lakh, a growth of 146% compared to the previous year. For the same year it recorded a net profit of ₹2.07 Lakh (net margin 7.5%) and EBITDA of ₹2.84 Lakh (EBITDA margin 10.3%). Revenue has grown at a compounded annual rate (CAGR) of 51% over three years.
Company details
Contact details
Biopharm Products Development and Innovation Private Limited's registered office is in Cuttack, Odisha.
- Registered AddressPlot No. 1532/3135 At – Ekbaruan Po – Niali, Cuttack, Odisha, India – 754294
- IndustryResearch & Development, Social Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biopharm Products Development and Innovation is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Biopharm Products Development and Innovation Private Limited, buy the company report.
Financials of Biopharm Products Development and Innovation Private Limited
FY 2025 filings availableBiopharm Products Development and Innovation Private Limited reported revenue of ₹27.68 Lakh (up 146% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 51% over three years, including 146% growth in the latest year. EBITDA rose 181% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.07 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.3% | ||||
| Net Profit Margin | 7.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biopharm Products Development and Innovation Private Limited, buy the company report.
Board of directors of Biopharm Products Development and Innovation Private Limited
Biopharm Products Development and Innovation has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bidhubhusan Badu | Managing Director | 19 Jul 2020 | 6 Years 4 Months | Current |
| Prajna Paramita Badu | Director | 23 Dec 2025 | 0 Years 10 Months | Current |
Peer comparison
Biopharm Products Development and Innovation Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Satleo Labs Private Limited | ₹27.86 Lakh (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Rise India Ventures Private Limited | ₹27.86 Lakh (FY 2024) | -28.0% | Puttaparthi, Andhra Pradesh, India | |||
| Anaisha Puranjay Earth Sciences Innovation Private Limited | ₹27.84 Lakh (FY 2025) | 36.0% | Ghaziabad, Uttar Pradesh, India | |||
| Upsoil Technologies (OPC) Private Limited | ₹27.71 Lakh (FY 2022) | -32.0% | Ganjam, Odisha, India | |||
| Biopharm Products Development and Innovation Private Limitedthis company | ₹27.68 Lakh (FY 2025) | ₹2.07 Lakh | 7.5% | 146.0% | Cuttack, Odisha, India | |
| Greenvention Biotech Private Limited | ₹27.58 Lakh (FY 2025) | 55.0% | Pune, Maharashtra, India | |||
| Ikesia Biologics Private Limited | ₹27.4 Lakh (FY 2024) | Bangalore, Karnataka, India | ||||
| Aaruni Lifesciences Private Limited | ₹27.35 Lakh (FY 2024) | 457.0% | Bangalore, Karnataka, India | |||
| Ayzer Labs Private Limited | ₹27.33 Lakh (FY 2025) | -1.0% | Kanpur, Uttar Pradesh, India | |||
| Appdron Machine Intelligence Private Limited | ₹27.2 Lakh (FY 2025) | -76.0% | Parathodu, Kerala, India |
To see the full peer comparison of Biopharm Products Development and Innovation Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biopharm Products Development and Innovation Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biopharm Products Development and Innovation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Biopharm Products Development and Innovation Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Biopharm Products Development and Innovation Private Limited has 5 board changes on record since 2020: 4 appointments and 1 cessation. The latest: Prajna Paramita Badu was appointed as Director on 23 Dec 2025.
Frequently asked questions
Biopharm Products Development and Innovation is an active private limited company based in Cuttack, Odisha, India. The company works in social science research, within the research and development industry. It was incorporated on 19 July 2020 (6+ years old) and is registered under CIN U73200OR2020PTC033481.
Biopharm Products Development and Innovation has 2 current directors:
- Bidhubhusan Badu - Managing Director
- Prajna Paramita Badu - Director
The latest financial statements of Biopharm Products Development and Innovation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Biopharm Products Development and Innovation is U73200OR2020PTC033481. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biopharm Products Development and Innovation was incorporated on 19 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Biopharm Products Development and Innovation by revenue are Satleo Labs Private Limited, Rise India Ventures Private Limited, Anaisha Puranjay Earth Sciences Innovation Private Limited, Upsoil Technologies (OPC) Private Limited, Greenvention Biotech Private Limited and 4 more, all in the same principal business activity (scientific research and development).
Prajna Paramita Badu was appointed as Director on 23 Dec 2025. Debabrata Sahoo ceased to be Director on 10 Mar 2023. Silachand Padhi was appointed as Director on 10 Mar 2023. Biopharm Products Development and Innovation has 5 board changes on record in total.
The registered office of Biopharm Products Development and Innovation is at Plot No. 15323135 At – Ekbaruan Po – Niali, Cuttack, Odisha, India – 754294.
Biopharm Products Development and Innovation operates in the research and development industry, in the social science research segment.
Biopharm Products Development and Innovation can be reached at its registered office: Plot No. 15323135 At – Ekbaruan Po – Niali, Cuttack, Odisha, India – 754294.
Biopharm Products Development and Innovation is registered under the jurisdiction of the Registrar of Companies (ROC), Cuttack.

